We are live on
!
Find out more
GA
General Atlantic Portfolio holdings
AUM
$2.91B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+24.21%
3 Year Est. Return
+168.27%
5 Year Est. Return
+91.75%
10 Year Est. Return
+1,020.11%
AUM
$2.91B
AUM Growth
+$759M
(+35%)
Cap. Flow
+$629M
Cap. Flow
% of AUM
21.63%
Top 10 Holdings %
Top 10 Hldgs %
98.97%
Holding
15
New
3
Increased
1
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LFTO
Liftoff Mobile
LFTO
|
+$656M |
| 2 |
SPTX
Seaport Therapeutics
SPTX
|
+$107M |
| 3 |
Alkami Technology
ALKT
|
+$66.7M |
| 4 |
PBLS
Parabilis Medicines Inc
PBLS
|
+$42.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EWCZ
European Wax Center
EWCZ
|
+$75.8M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$53.8M |
| 3 |
Revolution Medicines
RVMD
|
+$51.1M |
| 4 |
Pharvaris
PHVS
|
+$44.8M |
| 5 |
Nurix Therapeutics
NRIX
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Communication Services | 20.92% |
| 3 | Healthcare | 18.64% |
| 4 | Financials | 11.5% |
| 5 | Consumer Staples | 0.11% |
Similar funds
LSA
ACM
SCM
HWA
BWL
ISS
7WCP
JC
General Atlantic's Q2 2026 Portfolio in Review
As of Q2 2026, General Atlantic held 15 positions worth $2.91B, up 35% from $2.15B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
General Atlantic deployed $629M of net new capital in Q2 2026, opening 3 new positions and adding to 1 existing holding. Its largest new stake was Liftoff Mobile: 25,315,646 shares worth $608M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 59% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Revolution Medicines, an estimated $51.1M trimmed.
- General Atlantic's largest Q2 2026 buy was Liftoff Mobile: 25,315,646 shares worth $608M.
- General Atlantic added most to Alkami Technology in Q2 2026, an estimated $66.7M increase.
- General Atlantic's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $51.1M.
- General Atlantic fully exited European Wax Center in Q2 2026, selling an estimated $75.8M.
- General Atlantic's ten largest holdings make up 99% of its $2.91B portfolio in Q2 2026.
- General Atlantic opened 3 new positions and closed 3 in Q2 2026.
- General Atlantic's portfolio value rose 35% quarter-over-quarter to $2.91B.
Based on General Atlantic's 13F filing for Q2 2026, filed 14 Aug 2026.